You can edit almost every page by Creating an account and confirming your email.

BioSpring: Difference between revisions

From EverybodyWiki Bios & Wiki
WikiMasterBot2 (talk | contribs)
Moved page from wikipedia:en:BioSpring ([[Edithistory:|history]])
 
WikiMasterBot2 (talk | contribs)
m Moved page from wikipedia
 
Line 1: Line 1:
{{Short description|Organization}}
{{AFC submission|d|corp|u=SCN10A|ns=118|decliner=Grapesurgeon|declinets=20260601012431|ts=20260325002212}} <!-- Do not remove this line! -->
{{Infobox
| image            = [[File:BioSpring Logo Standard mit Claim.jpg|BioSpring Logo Standard mit Claim|530px]]
}}


'''BioSpring''' (alternatively named '''BioSpring GmbH''') is a [[contract manufacturing organization]]<ref name=":0">{{Cite web |title=Exclusive: German CDMO BioSpring embarks on €100M+ nucleic acid factory |url=https://endpoints.news/biospring-embarks-on-e100m-nucleic-acid-factory-in-germany/ |access-date=2025-08-08 |website=Endpoints News |language=en}}</ref><ref>{{Cite web |title=Careers |url=https://www.biospring.net/careers |access-date=2025-08-08 |website=www.biospring.net |language=en}}</ref><ref>{{Cite web |title=BioSpring {{!}} TIDES USA: Oligonucleotide & Peptide Therapeutics |url=https://informaconnect.com/tides/sponsors/biospring/ |access-date=2025-08-08 |website=informaconnect.com |language=en}}</ref> and [[contract manufacturer]].<ref>{{Cite web |last= |first= |title=BioSpring and Pantherna agree on strategic cooperation in the field of genome editing |url=https://www.drugdiscoverynews.com/biospring-and-pantherna-agree-on-strategic-cooperation-in-the-field-of-genome-editing-16042 |access-date=2025-08-08 |website=Drug Discover NewsDrug Discovery News, Development & Diagnostics Articles {{!}} DDN Magazine |language=en}}</ref><ref name=":1">{{Cite web |title=BioSpring Gesellschaft für Biotechnologie mbH (BioSpring GmbH) |url=https://www.life-sciences-germany.com/organisation/biospring-gesellschaft-fuer-biotechnologie-mbh-gmbh-group-1997-2001-9122.html |website=Life-Sciences-Germany.com}}</ref>
{{Short description|Contract manufacturer of therapeutic oligonucleotides }}
{{Draft topics|stem}}
{{AfC topic|org}}


The company develops [[nucleic acid]]<ref name=":4" />{{Page needed|date=August 2025}}<ref>{{Cite web |title=Home |url=https://www.biospring.net/ |access-date=2025-08-08 |website=www.biospring.net |language=en}}</ref><ref>{{Cite web |title=A New Era Begins: BioSpring Builds High-Tech Manufacturing Facility for Pharmaceutical Nucleic Acid APIs |url=https://www.bionity.com/en/news/1186629/a-new-era-begins-biospring-builds-high-tech-manufacturing-facility-for-pharmaceutical-nucleic-acid-apis.html |access-date=2025-08-08 |website=www.bionity.com |language=en}}</ref> and [[Oligonucleotide|oligonucleotides]].<ref name=":4">{{Cite book |title=1st Compass to Europe's Innovative Chemical Companies |publisher=BCNP Consultants GmbH |year=2015 |isbn=9783958800502}}</ref>{{Page needed|date=August 2025}}<ref>{{Cite journal |last1=Sattler |first1=Christian |last2=Ceylan |first2=Burak |last3=Hoffmann |first3=Luisa |last4=Juric |first4=Andela |last5=Kraus |first5=Julia |last6=Marandi |first6=Shima |last7=Shahnazari |first7=Aref |last8=Rühl |first8=Michael |date=2024-08-01 |title=Sequence confirmation of synthetic DNA exceeding 100 nucleotides using restriction enzyme mediated digestion combined with high-resolution tandem mass spectrometry |url=https://www.sciencedirect.com/science/article/pii/S0731708524002206 |journal=Journal of Pharmaceutical and Biomedical Analysis |volume=245 |article-number=116180 |doi=10.1016/j.jpba.2024.116180 |pmid=38703748 |issn=0731-7085}}</ref><ref name=":3">{{Cite web |title=DEAL - Magazine {{!}} Real Estate {{!}} Investment {{!}} Finance |url=http://www.deal-magazin.com/news/3/120976/BioSpring-expandiert-in-Offenbach-Bis-zu-1500-neue-Arbeitsplaetze |access-date=2025-08-08 |website=www.deal-magazin.com}}</ref><ref>{{Cite web |last=McCoy |first=Michael |date=2025-01-21 |title=BioSpring plans expansion in oligonucleotides |url=https://cen.acs.org/pharmaceuticals/pharmaceutical-chemicals/BioSpring-plans-expansion-oligonucleotides/101/i1 |access-date=2025-08-08 |website=Chemical & Engineering News |language=en}}</ref>
{{Infobox company
| name = BioSpring
| logo = BioSpring Logo Standard mit Claim.jpg
| type = [[Privately held company|Private]]
| ISIN =  
| industry = Pharmaceutical Manufacturing
| founded = 1997
| hq_location = Frankfurt a.M, Germany
| website = [https://www.biospring.net www.biospring.net]
}}'''BioSpring''' is a Contract Manufacturing and Development Organization ([[Contract manufacturing organization|CDMO]]) for Biotech and Pharma companies, specialized in oligonucleotides, and located in Frankfurt a.M. Germany.


== References ==
== History ==
{{Reflist}}
[[File:BioSpring_Illustration.jpg|thumb|Illustration BioSpring Headquarters G58, Alt-Fechenheim 34, Frankfurt]]
BioSpring was founded in 1997, by Hüseyin Aygün and Sylvia Wojczewski, then graduate students at Goethe-University-Frankfurt. BioSpring's headquarters are located in Frankfurt-Fechenheim and the company is still privately held and independent. Another production site is currently being built in neighboring Offenbach a.M.<ref>{{cite web|access-date=2025-01-13 |date=2022-12-17 |language=de |title=Expansion in Offenbach: 30.000 weitere Quadratmeter für Bio-Spring |url=https://www.op-online.de/offenbach/bio-spring-kauft-weitere-30-000-quadratmeter-auf-dem-offenbacher-innovationscampus-91980640.html}}<!-- auto-translated from German by Module:CS1 translator --></ref><ref>{{cite web|access-date=2025-01-13 |date=2022-12-16 |language=de |title=Biotech-Shootingstar Biospring expandiert in Offenbach |url=https://www.faz.net/aktuell/rhein-main/biotech-shootingstar-biospring-expandiert-in-offenbach-18539733.html}}<!-- auto-translated from German by Module:CS1 translator --></ref>


[[Category:Companies based in Frankfurt]]
The company employs about 600 people with 40 nationalities (as of March 2026). The average employee age is 33 years and half of employees and managers are female.
[[Category:Biotechnology companies]]
 
== Products ==
The active pharmaceutical ingredients, which BioSpring manufactures, serve diverse innovative treatments for formerly untreatable diseases, among others, cardiovascular diseases, metabolic diseases and neuromuscular diseases, and cancer.<ref>{{cite web|access-date=2025-01-13 |language=en |title=BioSpring hosts event on “Genome Editing – Medicine of the Future” in Frankfurt |url=https://www.biodeutschland.org/en/news/biospring-hosts-event-on-genome-editing-medicine-of-the-future-in-frankfurt.html}}<!-- auto-translated from German by Module:CS1 translator --></ref><ref>{{cite web|access-date=2025-01-13 |date=2024-02-09 |language=de |title=Am Puls der medizinischen Revolution |url=https://www.fnp.de/frankfurt/am-puls-der-medizinischen-revolution-92825003.html}}<!-- auto-translated from German by Module:CS1 translator --></ref><ref>{{cite web|access-date=2025-01-13 |language=en |title=BioSpring and Pantherna agree on strategic cooperation in the field of genome editing |url=https://www.drugdiscoverynews.com/biospring-and-pantherna-agree-on-strategic-cooperation-in-the-field-of-genome-editing-16042}}<!-- auto-translated from German by Module:CS1 translator --></ref> The company is specialized in the production and analysis of nucleic acids and specifically oligonucleotides. These molecules, which are short synthetic equivalents of natural genes, are being used in research and development, diagnostics and for therapeutic purposes. BioSpring also manufactures guide RNA for modern gene editing therapies, e.g. CRISPR/Cas9-based treatments.
Nuleic acids and oligonucleotides produced by BioSpring:
 
* Antisense Oligonucleotides (ASO)
* Small interfering RNA (siRNA)
* Guide RNA for genome editing purposes (e.g., CRISPR/Cas9)
* Aptamers
* mRNA
 
**
 
== Sources ==
<references />
[[:Category:Companies based in Frankfurt]]
[[:Category:Companies established in 1997]]
[[:Category:Biotechnology companies]]
{{⚠️🚨COPIED from EverybodyWiki ❗❕⚠️😡😤Please respect Licence CC-BY-SA ❗}}
{{⚠️🚨COPIED from EverybodyWiki ❗❕⚠️😡😤Please respect Licence CC-BY-SA ❗}}
{{Source Wikipedia}}
{{Source Wikipedia}}

Latest revision as of 09:34, 20 November 2026


BioSpring
Private
ISIN🆔
IndustryPharmaceutical Manufacturing
Founded 📆1997
Founder 👔
Headquarters 🏙️Frankfurt a.M, Germany
Area served 🗺️
Members
Number of employees
🌐 Websitewww.biospring.net
📇 Address
📞 telephone

BioSpring is a Contract Manufacturing and Development Organization (CDMO) for Biotech and Pharma companies, specialized in oligonucleotides, and located in Frankfurt a.M. Germany.

History

Illustration BioSpring Headquarters G58, Alt-Fechenheim 34, Frankfurt

BioSpring was founded in 1997, by Hüseyin Aygün and Sylvia Wojczewski, then graduate students at Goethe-University-Frankfurt. BioSpring's headquarters are located in Frankfurt-Fechenheim and the company is still privately held and independent. Another production site is currently being built in neighboring Offenbach a.M.[1][2]

The company employs about 600 people with 40 nationalities (as of March 2026). The average employee age is 33 years and half of employees and managers are female.

Products

The active pharmaceutical ingredients, which BioSpring manufactures, serve diverse innovative treatments for formerly untreatable diseases, among others, cardiovascular diseases, metabolic diseases and neuromuscular diseases, and cancer.[3][4][5] The company is specialized in the production and analysis of nucleic acids and specifically oligonucleotides. These molecules, which are short synthetic equivalents of natural genes, are being used in research and development, diagnostics and for therapeutic purposes. BioSpring also manufactures guide RNA for modern gene editing therapies, e.g. CRISPR/Cas9-based treatments. Nuleic acids and oligonucleotides produced by BioSpring:

  • Antisense Oligonucleotides (ASO)
  • Small interfering RNA (siRNA)
  • Guide RNA for genome editing purposes (e.g., CRISPR/Cas9)
  • Aptamers
  • mRNA

Sources

  1. ↑ "Expansion in Offenbach: 30.000 weitere Quadratmeter für Bio-Spring" (in Deutsch). 2022-12-17. Retrieved 2025-01-13.
  2. ↑ "Biotech-Shootingstar Biospring expandiert in Offenbach" (in Deutsch). 2022-12-16. Retrieved 2025-01-13.
  3. ↑ "BioSpring hosts event on "Genome Editing – Medicine of the Future" in Frankfurt". Retrieved 2025-01-13.
  4. ↑ "Am Puls der medizinischen Revolution" (in Deutsch). 2024-02-09. Retrieved 2025-01-13.
  5. ↑ "BioSpring and Pantherna agree on strategic cooperation in the field of genome editing". Retrieved 2025-01-13.

Category:Companies based in Frankfurt Category:Companies established in 1997 Category:Biotechnology companies


This article "BioSpring" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:BioSpring. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.